H.R. 9169

H.R. 9169: To support polycystic kidney disease research, and for other purposes.

Introduced Debbie Wasserman Schultz (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9169 is a bill introduced in the U.S. House of Representatives on June 4, 2026, aimed at supporting research into polycystic kidney disease (PKD). The bill has been referred to the House Committee on Energy and Commerce for further consideration. Specific details about the bill's provisions are not yet publicly available.

Positive Media Summary

While specific media coverage of H.R. 9169 is limited, similar legislative efforts have been positively received. For instance, the American Kidney Fund commended the introduction of the New Era of Preventing End-Stage Kidney Disease Act, highlighting its potential to improve diagnosis and awareness of rare kidney diseases. This suggests that H.R. 9169 may also garner support from patient advocacy groups and the medical community for its focus on PKD research.

Negative Media Summary

There is currently no specific negative media coverage of H.R. 9169. However, challenges faced by similar bills include concerns about funding allocation, potential bureaucratic delays, and the need for comprehensive strategies that address not only research but also patient care and access to treatments. These factors could influence the reception and implementation of H.R. 9169.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The bill H.R. 9169, which aims to support polycystic kidney disease research, does not show any direct industry overlaps with the sponsor Debbie Wasserman Schultz's top donor industries. The lobbying activity related to this bill involves various organizations, none of which appear to have a direct financial interest in the outcome of the legislation. For instance, Monroe Energy, LLC and Upstate Niagara Cooperative, Inc. contributed $10,000 each, but their interests do not align with kidney disease research. The absence of significant donor influence in this policy area suggests a low risk of conflict of interest. Voters should be aware that while there are contributions from various organizations, they do not directly relate to the bill's subject matter, indicating that the sponsor's legislative actions are likely not swayed by donor interests in this case.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
AMERICAN SUBCONTRACTOR ASSOCIATION OSCAR POLICY GROUP, LLC $30,000
AMERICAN COUNCIL OF INDEPENDENT LABORATORIES OSCAR POLICY GROUP, LLC $20,000
FINISHING TRADES INSTITUTE OF THE MID ATLANTIC REGION OSCAR POLICY GROUP, LLC $15,000
STEAMFITTERS LOCAL 420 OSCAR POLICY GROUP, LLC $12,000
MONROE ENERGY, LLC OSCAR POLICY GROUP, LLC $10,000
UPSTATE NIAGARA COOPERATIVE, INC. OSCAR POLICY GROUP, LLC $10,000
AGRI-MARK, INC OSCAR POLICY GROUP, LLC $10,000
FRIENDS OF FATHER JUDGE HIGH SCHOOL, INC. OSCAR POLICY GROUP, LLC $6,000
ARSENAL ASSOCIATES OSCAR POLICY GROUP, LLC undisclosed
LABOR & ENERGY ALLIANCE OSCAR POLICY GROUP, LLC undisclosed
BIG BROTHERS BIG SISTERS MIDDLE TENNESSEE OSCAR POLICY GROUP, LLC undisclosed
BIG BROTHERS BIG SISTERS INDEPENDENCE REGION OSCAR POLICY GROUP, LLC undisclosed
EKLUTNA, INC EKLUTNA, INC. undisclosed
CARPENTERS' COMPANY OF THE CITY AND COUNTY OF PHILADELPHIA OSCAR POLICY GROUP, LLC undisclosed
NATIONAL ELECTRICAL CONTRACTORS ASSOCIATION - PENN-DEL-JERSEY CHAPTER OSCAR POLICY GROUP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Debbie Wasserman Schultz, ranked by total contributions.

Health Professionals $600,000,000
Individuals: $600,000,000 PACs: $0
Retired $187,500,000
Individuals: $187,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us